Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co IncfiledCriticalMerck and Co Inc
Priority to ES0301310ApriorityCriticalpatent/ES301310A1/en
Publication of ES301310A1publicationCriticalpatent/ES301310A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Plural Heterocyclic Compounds
(AREA)
Abstract
Process for obtaining antiphlogistic compounds, which comprises contacting a 5 α -pregnan-3,6-dione with morpholine to form the corresponding 3-morpholin-5 α, 2-pregnen-6-one, treating this with triazohydrocarbon for obtain a mixture of the respective 6-oxo-5 α -pregnan- [3,2-d] -1'H (and 3'H) -1 ', 2', 3'-triazoles 1'- and 3'- substituted, and separate from that mixture 6-oxo-5 α -pregnan- [3,2-d] -1'H-1 ', 2', 3'-triazole-1'-substituted and 6-oxo-5 α -pregnan- [3,2-d] -3'H-1 ', 2', 3'-triazole 3'-substituted. (Machine-translation by Google Translate, not legally binding)
ES0301310A1964-06-161964-06-16Procedure for the obtaining of anti-flogistic compounds (Machine-translation by Google Translate, not legally binding)
ExpiredES301310A1
(en)
A procedure for the treatment of a mixture of symmetrical and asymmetric diclorotetrafluorethane. (Machine-translation by Google Translate, not legally binding)